The development of wearable non-invasive glucose sensors provides a convenient
technical means to monitor the glucose concentration of diabetes patients without …

Background and aim DM patients' antibody response after the COVID-19 vaccine is still
unknown amid the COVID-19 vaccination rollout. This study aimed to explore the SARS-CoV …

Background The association of COVID-19 with the development of new-onset diabetes has
been recently investigated by several groups, yielding controversial results. Population …

Aims This study aimed to assess the impact of different antidiabetic agents on individuals
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …

Telemedicine is a clinical approach that was seldom used in the day-to-day practice, if not
only in certain settings, before the COVID-19 pandemic. As stated by the WHO, telemedicine …

Introduction The COVID-19 pandemic disproportionately affected patients who had
comorbid diabetes mellitus. COVID-19 patients with diabetes experience significantly higher …

The ongoing coronavirus pandemic led to a rapid and dramatic increase in the use of
telehealth for diabetes care. In the wake of this transition, we examine new opportunities and …

Aims This systematic review and meta-analysis aims to investigate the effect of ivermectin on
mortality in patients with COVID-19. Methods A comprehensive systematic literature search …

Background Patients with type 2 diabetes mellitus (T2DM) have been reported to be more
susceptible to 2019 novel coronavirus (2019-nCoV) and more likely to develop severe …

Background COVID-19 might be a risk factor for various chronic diseases. However, the
association between COVID-19 and the risk of incident diabetes remains unclear. We aimed …